Development
Cardlytics, Inc.
CDLX
$1.79
$0.116.55%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.08% | 8.66% | 1.72% | -5.30% | -8.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.08% | 8.66% | 1.72% | -5.30% | -8.38% |
| Cost of Revenue | 0.98% | -7.57% | -4.66% | -4.51% | -7.05% |
| Gross Profit | 18.56% | 37.79% | 13.18% | -6.55% | -10.27% |
| SG&A Expenses | -24.88% | -22.32% | -26.73% | -29.04% | 3.63% |
| Depreciation & Amortization | -2.25% | -42.78% | -30.48% | -33.39% | -28.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.31% | -16.38% | -13.55% | -16.64% | -2.07% |
| Operating Income | 69.72% | 66.30% | 42.39% | 39.30% | -25.95% |
| Income Before Tax | 73.34% | -482.42% | 81.60% | -58.81% | -1,820.30% |
| Income Tax Expenses | -- | -- | -- | -- | 100.00% |
| Earnings from Continuing Operations | 73.34% | -482.42% | 81.39% | -58.81% | -3,096.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.34% | -482.42% | 81.39% | -58.81% | -3,096.27% |
| EBIT | 69.72% | 66.30% | 42.39% | 39.30% | -25.95% |
| EBITDA | 94.46% | 75.76% | 46.55% | 41.72% | -75.04% |
| EPS Basic | 77.42% | -431.76% | 82.05% | -58.63% | -3,093.93% |
| Normalized Basic EPS | 77.42% | 67.56% | 52.81% | 47.18% | 10.20% |
| EPS Diluted | 77.39% | -432.11% | 82.05% | -56.65% | -3,089.43% |
| Normalized Diluted EPS | 77.42% | 67.24% | 52.81% | 46.77% | 10.20% |
| Average Basic Shares Outstanding | 18.06% | 15.27% | 3.70% | -0.43% | 0.08% |
| Average Diluted Shares Outstanding | 18.06% | 14.17% | 3.70% | -1.23% | 0.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |